or
forgot password

    • cancer clinical trials in syracuse, NY

    • Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840031
    Syracuse, New York 13210
    Venous Thromboembolism, Cancer
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Sarcoma
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Syracuse Gastroenterological Associates
    Syracuse, New York 13210
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Syracuse Gastroenterological Associates
    Syracuse, New York 13210
    Ulcerative Colitis
    A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
    Regional Oncology Center
    Syracuse, New York 13210
    Carcinoma, Pancreatic Ductal, Pancreatic Cancer, Pancreatic Disease
    Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
    Associated Medical Professionals
    Syracuse, New York 13210
    Bladder Cancer Recurrence
    Bone Graft Materials Observational Registry
    Syracuse Orthopedic Specialists
    Syracuse, New York 13215
    Degenerative Disc Disease, Herniated Disc, Spinal Stenosis, Spondylolithesis, Spinal Deformity, Cervical Myelopathy, Failed Back Surgery Syndrome, Spinal Cord Neoplasms
    A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
    SUNY Upstate Medical University

    Trial Locations
    SUNY Upstate Medical University
    Syracuse VA Medical Center
    Bladder Cancer
    Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Amyotrophic Lateral Sclerosis
    Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (Cis) of the Bladder
    Associated Medical Professionals of New York
    Syracuse, New York 13210
    Carcinoma in Situ, Transitional Cell Carcinoma, Non-muscle Invasive Bladder Cancer
    Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
    Upstate Medical University
    Syracuse, New York 13210
    Chemotherapy-Induced Nausea and Vomiting